Definitive Healthcare股票讨论区

$Definitive Healthcare(DH.US)$ 🥱🥱🥱😁😁🤨👨‍🎓🚀🚀🚀🚀😛🚀😛😛🚀🚀🚀🚀🚀🚀🚀🚀😛😛🚀🚀🚀🚀

Upgrades
• $A.O.史密斯(AOS.US)$ : Longbow Research Upgrades to Buy from Neutral - PT $71
• $Callon Petroleum(CPE.US)$ : RBC Upgrades to Outperform from Sector Perform - PT $75
• $邓白氏(DNB.US)$ : BofA Securities Upgrades to Neutral from Underperform - PT $17 (from $16)
• $Enanta Pharmaceuticals(ENTA.US)$ : Evercore ISI Upgrades to Outperform from In Line - PT $62 (from $39)
• $康宁(GLW.US)$ : CFRA Upgrades to Strong Buy ...

2021 is a strong year for initial public offerings. This timing is right close to the easing of lockdowns. As we recalled back to 2019, it was a totally dissapointing market debuts and failures. Some highly anticipated tech cos such as $优步(UBER.US)$ made headlines for their lack of profitability. The public market spoke and Uber ended 219 with some of the most dissapointing public offerings.
Right now, the pipeline of prospects, IPO prospects is very strong driven by the pandemic. Personally, I think the resiliency of the economy is mainly driven by the hunger of the investors. More and more confidence coming to the markets $Definitive Healthcare(DH.US)$ $DICE THERAPEUTICS, INC.(DICE.US)$ $Brown & Brown(BRO.US)$ are some of the companies that set the tone. People feel like it's the right time for investors to take that equity risk.

IPOs see strong demand as investors are seeking new companies that offer innovative products and services in wide ranging and diverse areas. A number of well received IPOs have enjoyed terrific returns which could be attributed to market exuberance over these new listings. This comes as no surprise as the US market is the mainstay of most global portfolios of investors and also home to multiple fast growing companies across various industries. With the market reaching new all time highs, concerns are increasing about new listings overheating. The newly listed companies also tend to be more volatile during their first few earnings seasons as market expectations will rest on if they could deliver the promised targets. Investors need to be aware that early institutional investors look to exit their holdings within a year or so while retail investors are buying in, which results in increased volatility. Investment decisions should always be guided by a fundamental analysis of the company and its valuation to ensure that investors are not taking unnecessary risks to their portfolios by jumping on this IPO bandwagon blindly.
$Definitive Healthcare(DH.US)$
$DICE THERAPEUTICS, INC.(DICE.US)$
$Dutch Bros(BROS.US)$
$昂跑(ONON.US)$
$PROCEPT BioRobotics(PRCT.US)$
$Sportradar Group AG(SRAD.US)$
$Thoughtworks(TWKS.US)$
$Tyra Biosciences(TYRA.US)$